Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2026)
Monte Rosa Therapeutics (GLUE) recorded quarterly Tax Rate of 0.12% in Q1 2026, up 41.65% quarter-over-quarter from 0.2% in Q4 2025, and down 184.0% on a YoY basis from 0.14% in Q1 2025.
Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 0.12% for Q1 2026.
- In Q1 2026, Tax Rate fell 184.0% year-over-year to 0.12%; the TTM figure through Mar 2026 stood at 1.62% (down 3335.0% YoY), while the FY2025 annual figure was 4.75%, up 842.0% from the prior year.
- Tax Rate was 0.12% for Q1 2026 at Monte Rosa Therapeutics, up from 0.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 13.87% in Q4 2024 to a low of 10.81% in Q2 2025.
- Historically, Tax Rate has averaged 1.05% across 4 years, with a median of 0.23% in 2025.
- The sharpest annual moves came in 2024 and 2025: Tax Rate jumped 1380 bps in 2024, then plunged 1407 bps in 2025.
- A 4-year view of Tax Rate shows it stood at 0.07% in 2023, then surged by 20879 bps to 13.87% in 2024, then tumbled by 101 bps to 0.2% in 2025, then jumped by 42 bps to 0.12% in 2026.
- The last three Tax Rate figures came in at 0.12% (Q1 2026), 0.2% (Q4 2025), and 10.5% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 1.83 Bn | 1.15 Bn | - | -0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.12% |
| Mar 31, 2026 | -0.12% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | 10.50% |
| Sep 30, 2025 | 10.50% |
| Jun 30, 2025 | -10.81% |
| Jun 30, 2025 | -10.81% |
| Mar 31, 2025 | 1.72% |
| Mar 31, 2025 | 1.72% |
| Dec 31, 2024 | 13.87% |
| Dec 31, 2024 | 13.87% |
| Sep 30, 2024 | -0.30% |
| Sep 30, 2024 | -0.30% |
| Jun 30, 2024 | -0.84% |
| Jun 30, 2024 | -0.84% |
| Mar 31, 2024 | -0.26% |
| Mar 31, 2024 | -0.26% |
| Dec 31, 2023 | 0.07% |
| Dec 31, 2023 | 0.07% |